Ex vivo inhibition of β-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist

By Albert D. H.   Magoc T. J.   Menacherry S. D.   Morgan D. W.   Sun E.   Reyes A. E.   Kleinert H. D.   Carter G. W.   Summers J. B.  

Inflammation Research, Vol. 46, Iss. 7, 1997-07 ,pp. : 272-277

Springer Publishing Company

Access to resources Recommend Favorite

Bioassay-Guided Isolation of a Potent Platelet-Activating Factor Antagonist Alkenylresorcinol from Ardisia elliptica

By Jalil Juriyati   Jantan Ibrahim   Shaari Khozirah   Abdul Rafi Iftikhar Ahmad  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 42, Iss. 6, 2004-09 ,pp. : 457-461

Informa Healthcare

Access to resources Recommend Favorite

Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat

By Yoshikawa D.   Shiga T.   Saito S.   Morita T.   Imai T.   Goto F.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 241-245

Elsevier

Access to resources Recommend Favorite

Inhibitory effects of SY0916, a platelet-activating factor receptor antagonist, on the angiogenesis of human umbilical vascular endothelial cells

By Wu Lian-Qiu   OuYang Xue-Yu   Liu Yang   Peng Shan-Ying   Wang Lin   Wang Wen-Jie  

Journal of Asian Natural Products Research, Vol. 13, Iss. 11, 2011-10 ,pp. : 984-992

Taylor & Francis Ltd

Access to resources Recommend Favorite

Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation

By Lee L.-W.   Peng H.-C.   Ko W.-C.   Hung W.-C.   Su C.-H.   Lin C.-H.   Huang T.-F.   Yen M.-H.   Sheu J.-R.  

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 239-246

Elsevier

Access to resources Recommend Favorite